Unitaid

“Countries shouldn’t have to wait months before they can use new tools.” - Dr. Philippe Duneton

The Bundibugyo Ebola outbreak has highlighted major gaps in diagnostics and medical countermeasures.

Unitaid is investing up to US$3.4 million to prepare for access to promising new diagnostics and therapeutics, before they become available.

Working with Africa CDC, WHO, CHAI, PATH and The Aurum Institute, the investment is helping strengthen access planning and response capacity.

As global leaders prepare to meet in New York for the High-Level Meeting on Pandemic Prevention, Preparedness and Response, this is what preparedness looks like in practice:

Planning for access before a crisis demands it.

Read more: https://ow.ly/5H5950ZIcEk

Saving more children’s lives won’t always mean inventing something new. Sometimes, it means making better use of what we already have.

Pulse oximetry is a good example. It can help health workers identify children with dangerously low oxygen levels, but the device alone isn’t enough. It needs to be part of a system where referral, oxygen and treatment are available when needed.

As global health leaders gather in New York for , with maternal, newborn and child health among the issues in focus, this is an important part of the conversation: how do we turn proven solutions into everyday care?

For Unitaid, closing that gap between innovation and access is where lasting impact happens.

Read more: https://ow.ly/2i6t50ZIcb1

“TB is curable, but only if you catch it.” - Dr Neil Buddy Shah, CEO of CHAI

For millions of people, getting a TB diagnosis can be delayed simply because there isn’t a radiologist available to read their chest X-ray.

AI-powered screening can help change that.

Unitaid and Clinton Health Access Initiative are working with DeepTek and Delft Imaging to cut the cost of AI screening software by up to 65%, helping make faster TB detection more affordable.

Read how this could help bring TB detection closer to communities: https://ow.ly/OSlK50ZIaV5

What if Africa could be ready to produce new HIV prevention medicines before they become available?

Unitaid is supporting three African manufacturers to strengthen their capacity for the potential future production of alimatravir, a once-monthly HIV prevention pill currently in development.

Investing early in regional manufacturing can help lay the foundations for faster, more sustainable access to future HIV prevention innovations.

Read more: https://ow.ly/oh3O50ZIan7

Innovation is only the beginning.

As countries prepare to introduce a new generation of malaria prevention, we are investing US$36 million to generate the evidence needed to support effective rollout.

From spatial emanators to insecticide-treated baby wraps, the research will help turn promising innovations into greater impact against malaria.

Read more: https://ow.ly/V73350ZI8R5

Every day, over 700 women die from preventable causes related to pregnancy and childbirth.

One of the main causes is postpartum hemorrhage, which can become fatal within hours if not treated.

But in countries like Kenya and Nigeria, new tools and approaches are helping health workers detect bleeding earlier and respond faster.

In some settings, this has contributed to a 75% reduction in deaths.

When mothers survive, the impact extends far beyond the delivery room.